{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:43:44Z","timestamp":1792122224712,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["17-75-20054"],"award-info":[{"award-number":["17-75-20054"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health\/National Institute of Allergy and Infectious Diseases","award":["AI093772"],"award-info":[{"award-number":["AI093772"]}]},{"name":"National Institutes of Health\/National Institute of Allergy and Infectious Diseases","award":["AI105170"],"award-info":[{"award-number":["AI105170"]}]},{"name":"National Institutes of Health\/National Institute of Allergy and Infectious Diseases","award":["AI134132"],"award-info":[{"award-number":["AI134132"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.antiviral.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T18:45:12Z","timestamp":1557254712000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease"],"prefix":"10.1016","volume":"168","author":[{"given":"Tatiana","family":"Kotomina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Isakova-Sivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Matyushenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Rudenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.05.001_bib1","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1074\/jbc.R113.546218","article-title":"Eosinophil granule proteins: form and function","volume":"289","author":"Acharya","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.05.001_bib2","first-page":"3","article-title":"Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease","volume":"372","author":"Collins","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib3","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3390\/v5112881","article-title":"Human respiratory syncytial virus Memphis 37 grown in HEp-2 cells causes more severe disease in lambs than virus grown in Vero cells","volume":"5","author":"Derscheid","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.05.001_bib4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.05.001_bib5","series-title":"Development of Vaccines for Prevention of Respiratory Syncytial Virus (RSV) Disease in RSV- Na\u00efve Infants. 17 May 2017","article-title":"FDA briefing document","author":"FDA","year":"2017"},{"key":"10.1016\/j.antiviral.2019.05.001_bib6","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1128\/JVI.75.19.8899-8908.2001","article-title":"Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice","volume":"75","author":"Ferko","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib7","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus","volume":"151","author":"Graham","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CMR.00010-16","article-title":"Respiratory syncytial virus: infection, detection, and new options for prevention and treatment","volume":"30","author":"Griffiths","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2019.05.001_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2014.07.016","article-title":"Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis","volume":"110C","author":"Hwang","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.001_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.virol.2017.08.022","article-title":"Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus","volume":"511","author":"Hwang","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.05.001_bib11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/CVI.00819-13","article-title":"Characterization of reverse genetics-derived cold-adapted master donor virus A\/Leningrad\/134\/17\/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model","volume":"21","author":"Isakova-Sivak","year":"2014","journal-title":"Clin. Vaccine Immunol. : CVI"},{"key":"10.1016\/j.antiviral.2019.05.001_bib13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1080\/14760584.2016.1208088","article-title":"Cold-adapted influenza viruses as a promising platform for viral-vector vaccines","volume":"15","author":"Isakova-Sivak","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2019.05.001_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10517-016-3454-7","article-title":"Analysis of immune epitopes of respiratory syncytial virus for designing of vectored vaccines based on influenza virus platform","volume":"161","author":"Isakova-Sivak","year":"2016","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2019.05.001_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib16","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.001_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1746-6148-9-123","article-title":"Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review","volume":"9","author":"Klopfleisch","year":"2013","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.antiviral.2019.05.001_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004757","article-title":"RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets","volume":"11","author":"Knudson","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.05.001_bib19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/14760584.2018.1541407","article-title":"Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine","volume":"17","author":"Korenkov","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2019.05.001_bib20","first-page":"1","article-title":"Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site","author":"Kotomina","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2019.05.001_bib21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s12275-017-7306-6","article-title":"Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8(+) T-cell immunity against respiratory syncytial virus infection","volume":"55","author":"Lee","year":"2017","journal-title":"J. Microbiol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib22","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1080\/21645515.2017.1362514","article-title":"Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles","volume":"13","author":"Lee","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2019.05.001_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/bioe.21950","article-title":"Engineering influenza viral vectors","volume":"4","author":"Li","year":"2013","journal-title":"Bioengineered"},{"key":"10.1016\/j.antiviral.2019.05.001_bib24","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates","volume":"18","author":"Mazur","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.05.001_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0192623308329342","article-title":"Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model","volume":"37","author":"Meyerholz","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/infdis\/jix165","article-title":"Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination","volume":"215","author":"Mohn","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.05.001_bib27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/mi.2016.48","article-title":"Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung","volume":"10","author":"Morabito","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/CVI.00037-16","article-title":"Progress toward a respiratory syncytial virus vaccine","volume":"23","author":"Neuzil","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib29","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.4049\/jimmunol.179.8.5415","article-title":"CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"179","author":"Olson","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coviro.2013.05.005","article-title":"Protective and dysregulated T cell immunity in RSV infection","volume":"3","author":"Openshaw","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1513\/pats.200501-002AW","article-title":"Pathogenesis of respiratory syncytial virus infection in the murine model","volume":"2","author":"Peebles","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.antiviral.2019.05.001_bib32","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/mtm.2015.18","article-title":"Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates. Molecular therapy","volume":"2","author":"Pierantoni","year":"2015","journal-title":"Methods Clin. Dev."},{"key":"10.1016\/j.antiviral.2019.05.001_bib33","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1099\/0022-1317-82-11-2663","article-title":"Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine","volume":"82","author":"Ponnuraj","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006810","article-title":"Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection","volume":"14","author":"Schmidt","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.05.001_bib35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.05.001_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.186.3.421","article-title":"Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection","volume":"186","author":"Srikiatkhachorn","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.05.001_bib37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10517-019-04407-1","article-title":"Amino acid substitutions N123D and N149D in hemagglutinin molecule enhance immunigenicity of live attenuated influenza H7N9 vaccine strain in experiment","volume":"166","author":"Stepanova","year":"2019","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2019.05.001_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2007.07.011","article-title":"Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry","volume":"327","author":"Stevens","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2019.05.001_bib40","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1128\/JVI.01693-10","article-title":"Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB\/c mice","volume":"85","author":"Stokes","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5757","article-title":"Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections","volume":"7","author":"Taylor","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2019.05.001_bib42","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1128\/JVI.02372-07","article-title":"Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection","volume":"82","author":"Yu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.001_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85832","article-title":"Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection","volume":"1","author":"Zens","year":"2016","journal-title":"JCI insight"},{"key":"10.1016\/j.antiviral.2019.05.001_bib44","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1016\/j.vaccine.2010.08.106","article-title":"NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets","volume":"28","author":"Zhou","year":"2010","journal-title":"Vaccine"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T09:50:17Z","timestamp":1694857817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219301214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":42,"alternative-id":["S0166354219301214"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}